The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion
The ongoing Covid-19 pandemic propelled pharmaceutical company Pfizer’s earnings to a record $100 billion last year, almost $57 billion of which was driven by its vaccine and antiviral pill Paxlovid, the company reported Tuesday.
Published 4 months ago · New York, United States
Time & Location
Sources are mostly out of (0)
Bias Distribution
56% of the sources lean Left
L 56%
C 33%
11%
See less detail
